News
Comorbidities, hematologic cancers drive high costs among elderly patients
In a retrospective cost analysis of cancer-related inpatient visits among patients 65 or older, the top 10% of hospital visits were almost five...
News
Real world responses mirror TOURMALINE-MM1 data
GLASGOW – Median progression-free survival was more than 20 months in real-world patients who received triplet therapy, similar to findings from...
News
Whole-genome sequencing demonstrates clinical relevance
GLASGOW – A study comparing whole-genome sequencing (WGS) with fluorescence in situ hybridization showed that the WGS was reliable and clinically...
News
For endometrial cancer, postop taxane/platinum competes with standard therapy
In patients with endometrial cancer at high risk of progression, 5-year overall survival was 82.7% for doxorubicin/cisplatin, 86.1% for paclitaxel...
News
For patients with HBV, daily aspirin may reduce risk of liver cancer
Sixteen years of data showed that daily aspirin therapy reduced the risk of HBV-related hepatocellular carcinoma by 29%.
News
Surge of gabapentinoids for pain lacks supporting evidence
Review of 54 papers for gabapentin and 30 for pregabalin finds little evidence for effective pain control in off-label uses.
News
Rituximab boosts survival in primary CNS lymphoma
The triplet combination of rituximab plus combination high-dose methotrexate and temozolomide could be a safe and effective first-line option for...
News
Cirrhosis model predicts decompensation across diverse populations
During model development, the hazard ratio for decompensation was 7.10 among patients with high risk scores.
News
Worse survival seen among black patients with MCL
There was a survival gap between black and white patients, even though black patients with mantle cell lymphoma were more likely to be treated in...
Article
Infant survival rate after HCT remains flat
Survival rates remained largely unchanged from 2000-2014 for infants who underwent allogeneic hematopoietic cell...
News
MitraClip improves survival and health status for at least 2 years
The health status findings further support the device as a valuable treatment option for heart failure patients with severe secondary mitral...
News
Ovarian cancer survivors carry burden of severe long-term fatigue
Women who have survived epithelial ovarian cancer (EOC) more often report severe long-term fatigue than healthy women, according to a case-control...
News
Weekly turoctocog alfa pegol is feasible for hemophilia A
An extension of the pathfinder 2 trial produced encouraging results with providing a stepped-down regimen in severe hemophilia A patients.
News
Erectile dysfunction appears prevalent with hemophilia
A survey of men with hemophilia reveals that erectile dysfunction may be fairly common with the bleeding disorder and that its prevalence...
News
Case report may link gluteal implants to lymphoma
On the heels of increased reports of breast implant–related anaplastic large cell lymphoma, researchers report a case of lymphoma that may be...